Reuters logo
BRIEF-Janssen announces FDA approval of Juluca for the treatment of HIV-1 infection
November 21, 2017 / 11:28 PM / 23 days ago

BRIEF-Janssen announces FDA approval of Juluca for the treatment of HIV-1 infection

Nov 21 (Reuters) - ‍Janssen Therapeutics

* Janssen announces U.S. FDA approval of first and only complete, single-pill, two-drug regimen, Juluca (dolutegravir and rilpivirine), for the treatment of HIV-1 infection

* says U.S. FDA approval for single-pill, two-drug regimen, juluca for treatment of HIV-1 infection​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below